Increased [ 3H]D-aspartate release and changes in glutamate receptor expression in the hippocampus of the mnd mouse

Journal of Neuroscience Research

Volumn 90, Issue 6, 2012, Pages 1148-1158

  Bigini, Paolo ^a   Milanese, Marco ^b   Gardoni, Fabrizio ^b   Longhi, Annalisa ^b   Bonifacino, Tiziana ^b   Barbera, Sara ^a   Fumagalli, Elena ^a   Di Luca, Monica ^b   Mennini, Tiziana ^a   Bonanno, Giambattista ^b,c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Italian Institute of Neuroscience   (Italy)

Author keywords

Epilepsy; Excitotoxicity; Glutamate release; Mnd mice; Neuronal ceroid lipofuscinoses; Neuronal hyperexcitability

Indexed keywords

AMPA RECEPTOR; ASPARTIC ACID; CALCIUM; GLUTAMATE RECEPTOR; IONOMYCIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; POTASSIUM CHLORIDE; THREO BETA BENZYLOXYASPARTIC ACID; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; EXOCYTOSIS; GENE EXPRESSION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; MALE; MOUSE; NERVE CELL EXCITABILITY; NEURONAL CEROID LIPOFUSCINOSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SEIZURE;

ANALYSIS OF VARIANCE; ANIMALS; ASPARTIC ACID; ASTROCYTES; CALCIUM IONOPHORES; D-ASPARTIC ACID; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IONOMYCIN; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; POTASSIUM CHLORIDE; RECEPTORS, GLUTAMATE; SYNAPTOSOMES; TRITIUM;

EID: 84859446256     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22831     Document Type: Article

References (37)

1. Bigini P, Gardoni F, Barbera S, Cagnotto A, Fumagalli E, Longhi A, Corsi MM, Di Luca M, Mennini T. 2006. Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice. BMC Neurosci 7: 71.
2. Bolivar VJ, Scott Ganus J, Messer A. 2002. The development of behavioral abnormalities in the motor neuron degeneration (mnd) mouse. Brain Res 937: 74-82.
3. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
4. Cooper JD, Russell C, Mitchison HM. 2006. Progress towards understanding disease mechanisms in small vertebrate models of neuronal ceroid lipofuscinosis. Biochim Biophys Acta 1762: 873-889.
5. Elger B, Schneider M, Winter E, Carvelli L, Bonomi M, Fracasso C, Guiso G, Colovic M, Caccia S, Mennini T. 2006. Optimized synthesis of AMPA receptor antagonist ZK 187638 and neurobehavioral activity in a mouse model of neuronal ceroid lipofuscinosis. Chem Med Chem 1: 1142-1148.
6. Fassio A, Sala R, Bonanno G, Marchi M, Raiteri M. 1999. Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F. Neuroscience 90: 893-902.
7. Frasca A, Aalbers M, Frigerio F, Fiordaliso F, Salio M, Gobbi M, Cagnotto A, Gardoni F, Battaglia GS, Hoogland G, Di Luca M, Vezzani A. 2011. Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity. Neurobiol Dis 43: 507-515.
8. Guarneri R, Russo D, Cascio C, D'Agostino S, Galizzi G, Bigini P, Mennini T, Guarneri P. 2004. Retinal oxidation, apoptosis and age- and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis. Brain Res 1014:209-220.
9. Goebel HH, Wisniewski KE. 2004. Current state of clinical and morphological features in human NCL. Brain Pathol 14: 61-69.
10. Haltia M. 2003. The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol 62: 1-13.
11. Holt M, Jahn R. 2004. Neuroscience. Synaptic vesicles in the fast lane. Science 303: 1986-1987.
12. Lau CG, Zukin RS. 2007. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8: 413-426.
13. Lee MC, Ting KK, Adams S, Brew BJ, Chung R, Guillemin GJ. 2010. Characterisation of the expression of NMDA receptors in human astrocytes. PLoS One 5: e14123.
14. Levi G, Raiteri M. 1993. Carrier-mediated release of neurotransmitters. Trends Neurosci 16: 415-419.
15. Lipman RD, Donohue LR, Hoppe P, Bronson RT. 1996. Evidence that lysosomal storage of proteolipids is a cell autonomous process in the motor neuron degeneration (mnd) mouse, a model of neuronal ceroid lipofuscinosis. Neurosci Lett 219: 111-114.
16. Mazurkiewicz JE, Callahan LM, Swash M, Martin JE, Messer A. 1993. Cytoplasmic inclusions in spinal neurons of the motor neuron degeneration (mnd) mouse. I. Light microscopic analysis. J Neurol Sci 116: 59-66.
17. Melo T, Bigini P, Sonnewald U, Balosso S, Cagnotto A, Barbera S, Uboldi S, Vezzani A, Mennini T. 2010. Neuronal hyperexcitability and seizures are associated with changes in glial-neuronal interactions in the hippocampus of a mouse model of epilepsy with mental retardation. J Neurochem 115: 1445-1454.
18. Mennini T, Bastone A, Crespi D, Comoletti D, Manzoni C. 1998. Spinal cord GLT-1 glutamate transporter and blood glutamic acid alterations in motor neuron degeneration (mnd) mice. J Neurol Sci 157: 31-36.
19. Mennini T, Cagnotto A, Carvelli L, Comoletti D, Manzoni C, Muzio V, Rizzi M, Vezzani A. 1999. Biochemical and pharmacological evidence of a functional role of AMPA receptors in motor neuron dysfunction in mnd mice. Eur J Neurosci 11: 1705-1710.
20. Mennini T, Bigini P, Ravizza T, Vezzani A, Calvaresi N, Tortarolo M, Bendotti C. 2002. Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder. J Neurosci Res 70: 553-560.
21. Messer A, Plummer J. 1993. Accumulating autofluorescent material as a marker for early changes in the spinal cord of the Mnd mouse. Neuromuscul Disord 3: 129-134.
22. Messer A, Plummer J, Wong V, Lavail MM. 1993. Retinal degeneration in motor neuron degeneration (mnd) mutant mice. Exp Eye Res 57:637-641.
23. Messer A, Strominger NL, Mazurkiewicz JE. 1987. Histopathology of the late-onset motor neuron degeneration (mnd) mutant in the mouse. J Neurogenet 4: 201-213.
24. Milanese M, Zappettini S, Onofri F, Musazzi L, Tardito D, Bonifacino T, Messa M, Racagni G, Usai C, Benfenati F, Popoli M, Bonanno G. 2011. Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. J Neurochem 116: 1028-1042.
25. Nakamura Y, Iga K, Shibata T, Shudo M, Kataoka K. 1993. Glial plasmalemmal vesicles: a subcellular fraction from rat hippocampal homogenate distinct from synaptosomes. Glia 9: 48-56.
26. Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y, Smith T. 2008. Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 18: 52-61.
27. Paluzzi S, Alloisio S, Zappettini S, Milanese M, Raiteri L, Nobile M, Bonanno G. 2011. Adult astroglia is competent for Na+/Ca2+ exchanger-operated exocytotic glutamate release triggered by mild depolarization. J Neurochem 103:1196-1207.
28. Raiteri L, Raiteri M. 2000. Synaptosomes still viable after 25 years of superfusion. Neurochem Res 25: 1265-1274.
29. Raiteri L, Raiteri M, Bonanno G. 2002. Coexistence and function of different neurotransmitter transporters in the plasma membrane of CNS neurons. Prog Neurobiol 68: 287-309.
30. Ranta S, Topcu M, Tegelberg S, Tan H, Ustubutun A, Saatci I, Dufke A, Enders H, Pohl K, Alembik Y, Mitchell WA, Mole SE, Lehesjoki AE. 2004. Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum Mutat 23:300-305.
31. Sanchez-Prieto J, Sihra TS, Nicholls DG. 1987. Characterization of the exocytotic release of glutamate from guinea-pig cerebral cortical synaptosomes. J Neurochem 49: 58-64.
32. Seifert G, Steinhauser C. 2011. Neuron-astrocyte signaling and epilepsy. Exp Neurol (in press).
33. Seifert G, Huttmann K, Schramm J, Steinhauser C. 2004. Enhanced relative expression of glutamate receptor 1 flip AMPA receptor subunits in hippocampal astrocytes of epilepsy patients with Ammon's horn sclerosis. J Neurosci 24: 1996-2003.
34. 2+-binding site in the pore of cyclic nucleotide-gated channels: S5/S6 segments control affinity of intrapore glutamates. EMBO J 18: 119-130.
35. Shimamoto K, Lebrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, Yumoto N, Nakajima T. 1998. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharmacol 53: 195-201.
36. Stigliani S, Zappettini S, Raiteri L, Passalacqua M, Melloni E, Venturi C, Tacchetti C, Diaspro A, Usai C, Bonanno G. 2006. Glia re-sealed particles freshly prepared from adult rat brain are competent for exocytotic release of glutamate. J Neurochem 96: 656-668.
37. Trikash IO, Volynets GP, Remenyak OV, Gorchev VF. 2008. Docking and fusion of synaptic vesicles in cell-free model system of exocytosis. Neurochem Int 53: 401-407.